Podcasts about Johns Hopkins

Our information environment has become a social determinant of health. In this episode, Joshua Sharfstein, a public health leader and professor at Johns Hopkins, and Joanne Kenen, journalist in residence at the Johns Hopkins Bloomberg School of Public Health, discuss how the collapse of local journalism, the design of social media algorithms, and politicization have created an “information sickness” that undermines personal and public health. They explain that traditional reporting once filtered out false claims through rules and accountability, while today's engagement-driven platforms reward emotional misinformation that quickly becomes “sticky.” The guests explore the consequences of vaccine refusal, fractured families, and the urgent need for remedies, such as embedding misinformation experts in health agencies, utilizing trusted platforms, and fostering community trust. They emphasize that artificial intelligence will both fuel and fight misinformation, demanding institutional adaptation. Ultimately, they urge individuals to maintain an informed news diet and practice empathy across information divides, reminding listeners that public health must serve everyone, even those who disagree. Tune in to learn practical ways to counter health misinformation, from rapid pre-bunking to community partnerships and smarter use of AI! Resources: Connect with and follow Joshua Sharfstein on LinkedIn. Follow and connect with Joanne Kenen on LinkedIn. Learn more about Johns Hopkins Bloomberg School of Public Health on their LinkedIn and website. Buy Josh and Joanne's book Information Sick here. Listen to the What The Health podcast here. Sign up for the Expert Insights Newsletter here. Learn more about your ad choices. Visit megaphone.fm/adchoices

About this episode: Millions of people across the globe continue to grapple with debilitating long COVID symptoms, as researchers untangle the unknowns of the condition. In this episode: Alba Azola, who leads long COVID research and treatment at Johns Hopkins, lays out the data on who's being diagnosed with long COVID, available treatment options, and the future of post-infectious chronic disease research. Guests: Dr. Alba Azola is a rehabilitation physician and the co-director of the Long COVID/Chronic Fatigue Syndrome Clinic at Johns Hopkins Medicine. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Researching COVID to Enhance Recovery—RECOVER 4 years later, experts are just beginning to 'scratch the surface' of understanding long COVID—ABC News Unraveling Long COVID's Causes and Impacts—Hopkins Bloomberg Public Health Magazine BONUS: Checking In With A COVID Long-hauler—Public Health On Call (November 2021) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In-utero procedures can yield better long-term outcomes for the baby. However, fetal surgery relies on instruments developed for other disciplines. An early-stage startup in Maryland is developing in-utero instruments to improve outcomes for both fetus and mother.Fetal Therapy Technologies CEO Selena Shirkin joins Key Tech's Andy Rogers for Episode 42 of the MedTech Speed to Data podcast to discuss startup innovation in fetal surgery.Need to knowFetal surgeries carry risks — In addition to uterine damage complicating future pregnancies, 40% of surgeries have a risk of preterm birth.Few specialized tools are used — In the field's forty-year history, the FDA has only approved the Karl Storz Fetoscope for use in fetal surgeries.Off-label device use is widespread — Equipment borrowed from adjacent fields like laparoscopy and neurosurgery weren't indicated for use in the uterus.The nitty-grittyShirkin and Chief Technology Officer Eric McAlexander founded Fetal Therapy Technologies as students in Johns Hopkins University's biomedical engineering graduate program. While shadowing surgeons, they saw how off-label instruments complicated procedures.“I watched a surgeon using a grasper and suture,” Shirkin recalled. “The suture was falling out of the grasper because they didn't fit. It took time in the surgery to make sure that didn't occur.”Observations like these led the team to wonder why the field lacked optimized tools. “As biomedical engineers,” Shirkin says, “we asked ourselves what if we created those purpose-built instruments that actually make these procedures safer?”They quickly ran into the commercial limits of a market as small as fetal surgery. With only one device FDA-approved for in-uterine procedures, surgeons have no choice but to use devices off-label. So Fetal Therapy Technologies is flipping the script by leveraging the broader applications of an instrument designed for fetal surgeries.“In a way, our company solves two problems at once,” Shirkin says. “A company that creates a fetal innovation [that] also raises a much broader market of general microsurgery.”Their first product is a uterine port. “Similar to laparoscopic surgeries,” Shirkin explains, “that involves inserting a port through the abdomen into the uterus. [The new] port is designed to leverage the elastic properties of the uterine environment to make entry safer than the current clinical standard.”For broader commercialization, they aim to demonstrate equivalence to predicate devices and qualify as a 510(k) Class II device following benchtop and animal studies. Approval for fetal surgeries is a longer journey, but the company can build on its data before entering human trials.Data that made the difference:Shirkin offered insights for other students considering an entrepreneurial future in MedTech.Leverage university resources. “We work incredibly closely with the Johns Hopkins Center for Fetal Therapy,” Shirkin says. We've also gotten opportunities from Johns Hopkins Technology Ventures.”Build a network of advisors. “We are supported by a very broad variety of clinical, technical, and business mentors across the Johns Hopkins ecosystem and beyond.”Tap into local funding sources. “There's a lot of collegiate business plan competitions that we've been very successful [raising] non-dilutive funds that way. There are also state-level grants. We just received a Baltimore Innovation Initiative grant.”

When we think of perimenopause, we hear about hot flashes—but what about the mood swings, anxiety, and depression no one talks about?In this episode, Sarah sits down with Reproductive Psychiatrist Dr. Lindsay Standeven to break down the mental health side of perimenopause. They talk about why women are more likely to face depression during this stage, what it means if you've struggled in pregnancy or postpartum, and—most importantly—what you can do now to protect your mental health.About Dr. Lindsay R. Standeven:Dr. Lindsay R. Standeven is a Clinical Associate Professor in the Department of Psychiatry at the University of Colorado School of Medicine and Adjunct Faculty at Johns Hopkins. After completing her residency training at Johns Hopkins Hospital, Dr. Standeven completed a two-year research and clinical fellowship specializing in reproductive psychiatry. Dr. Standeven spent the earlier part of her career on the faculty at Johns Hopkins, serving as the clinical and education director for the Johns Hopkins Reproductive Mental Health Center, where she oversaw clinical staff and taught psychiatry residents in reproductive psychiatry.She is passionate about teaching and advocacy in women's mental health and serves as a member of the National Curriculum in Reproductive Psychiatry, where she helped spearhead a training program in women's mental health for psychiatrists across the country. Her clinical expertise is in helping individuals struggling with mood-related changes due to pregnancy, postpartum, infertility, reproductive loss, Polycystic Ovary Syndrome, premenstrual syndrome, and perimenopause.

This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee continue their forensic review of the 2011 death of Ellen Greenberg, a young woman found with more than twenty stab wounds in her Philadelphia apartment. Picking up where part one left off, Dr. Priya discusses the two critical stab wounds that penetrated Ellen's brain stem and spinal cord; injuries she believes would have rendered her incapable of any further self-harm. From the anatomy of the cervical spine to the forensic interpretation of bruising, Dr. Priya explains why the medical evidence in this case still challenges the official ruling of suicide, and why the Greenberg family continues to fight for justice. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl McCollum and Dr. Priya introduce part two of the Ellen Greenberg case (1:45) Dr. Priya describes how she documents injuries and explains why numbering stab wounds can mislead investigators (2:45) The base-of-skull wounds, and how it penetrated the dura, disrupting vital brainstem functions (4:45) The cervical-spine injury between C2 and C3 and how Ellen’s neurological injuries could explain the absence of defensive wounds (10:45) Distinguishing the possible order of injuries, and why positioning and directionality are critical in understanding the sequence of events (13:15) "History of mental illness does not make you suicidal.” Dr. Priya explains why psychiatric history must be interpreted cautiously in death investigations (14:15) Brusing: what it can and cannot tell investigators about struggle, timing and prior assaults (20:00) Dr. Priya reflects on the Greenberg family’s courage, and the power of their love to keep fighting for the truth About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

Summary This podcast episode from the Boss Surgery Series features Dr. Amy Vertries interviewing Dr. Sarah Rasmussen, a pediatric transplant surgeon, about her experience of being in the wrong job and navigating a career transition. Dr. Rasmussen shares her journey from working at the University of Virginia (UVA) to Seattle Children's Hospital and then to a new position that better aligned with her career goals and values. Dr. Rasmussen begins by describing her background as a Gen-Xer born in West Virginia who initially planned to practice medicine with her father. She pursued an MD-PhD program at WVU in 1997, focusing on HIV research at the National Cancer Institute. During her medical training, she discovered her passion for surgery during rotations and completed her residency at Virginia Commonwealth University followed by a pediatric surgery fellowship at Johns Hopkins. She then worked at UVA from 2011 to 2020, where she established a pediatric liver transplant program in partnership with Children's Hospital of Pittsburgh. Dr. Rasmussen explains that leadership changes at UVA led to her role being reduced from performing 42 liver transplants annually to being limited to only pediatric cases (about 5 per year). This significant reduction in surgical volume prompted her to accept a position at Seattle Children's Hospital as the surgical director of pediatric liver transplant, which she accepted just before the COVID-19 pandemic began in early 2020. At Seattle Children's, Dr. Rasmussen encountered challenges that made her realize she was in the wrong job. Despite the hospital performing more transplants (13-15 liver transplants and 30 kidney transplants annually), she faced issues with case allocation, micromanagement of her decisions, and resistance to her suggestions for improving processes. After 18 months, she compiled data showing her limited involvement in transplant cases and presented it to leadership, hoping for change. Instead, this led to increased scrutiny of her abilities. Dr. Rasmussen describes how the job stress affected her health, causing panic attacks, chest pain, and dangerously high blood pressure. With support from her family and through Dr. Vertries' coaching program, she decided to explore other opportunities. She interviewed at four institutions and found a position with a partner who shared her vision and valued her contributions. In her new role, Dr. Rasmussen found a supportive environment where her partner encourages her growth, helps her through complications, and values her strengths. She shares how her new partner supported her through a surgical complication by not letting her isolate herself and helping her move past self-doubt. He also encourages her to take on challenging cases, such as performing laparoscopic procedures on very small infants. The conversation concludes with reflections on the importance of finding the right job fit, the impact of career decisions on family, and how having the right partner can make a significant difference in professional growth and satisfaction. Chapters Dr. Rasmussen's Background and Early Career Path ‎ 00:02:12 Dr. Sarah Rasmussen introduces herself as a Gen-Xer born in West Virginia. She initially planned to practice medicine with her father but became interested in research during medical school. She joined an MD-PhD program at WVU in 1997, focusing on HIV research at the National Cancer Institute. During her clinical rotations, she discovered her passion for surgery, which engaged "all parts of her brain." She completed her residency at Virginia Commonwealth University and a pediatric surgery fellowship at Johns Hopkins. From 2011 to 2020, she worked at the University of Virginia (UVA) as an assistant professor, where she also completed an additional fellowship in abdominal transplant surgery. At UVA, she was active in research, clinical work, teaching, and helped establish a pediatric liver transplant program in partnership with Children's Hospital of Pittsburgh. Transition to Seattle Children's Hospital During the Pandemic ‎ 00:05:21 Dr. Rasmussen explains that leadership changes at UVA led to her role being reduced from performing 42 liver transplants annually to being limited to only pediatric cases (about 5 per year). This significant reduction prompted her to accept a position as surgical director of pediatric liver transplant at Seattle Children's Hospital. She signed her offer letter just before the COVID-19 pandemic began, making the transition particularly challenging as it occurred during social distancing measures. Dr. Rasmussen was attracted to Seattle Children's because they performed more transplants (13-15 liver transplants and 30 kidney transplants annually), and she believed she would have a good working relationship with the program head who had similar training. Challenges at Seattle Children's Hospital ‎ 00:09:27 Dr. Rasmussen describes her initial positive reception at Seattle Children's but quickly noticed concerning dynamics between surgeons during her observation of a liver-kidney transplant on her second day. Despite her efforts to integrate into the team, she faced significant challenges: her clinical decisions were micromanaged, her requests for time off were complicated by "unwritten rules," and she was often excluded from transplant cases because "fellows needed the experience." After 12 months, she realized that her situation wasn't improving despite her efforts to be helpful and engaged. After 18 months, she compiled data showing her limited involvement in transplant cases (only 20% of livers and 15% of kidneys despite being on call 33% of the time) and presented it to leadership, hoping for change. Instead of addressing her concerns, this led to increased scrutiny of her abilities. Recognizing the Need for Change ‎ 00:16:45 Dr. Rasmussen sought advice from colleagues but was consistently told that the situation "would never change." She realized that her vision of being a pediatric liver transplant surgeon required meaningful involvement in cases, which wasn't happening at Seattle. In January 2021, she learned of four potential job openings in her field. Initially resistant to moving her family again so soon after relocating during the pandemic, she joined Dr. Vertries' "difficult partner course" hoping to learn how to succeed in her current position. Through the course, she gave herself permission to explore other opportunities and interviewed at all four institutions. Two positions seemed promising, with one standing out immediately because of her connection with the potential new boss. Health Impact and Decision to Leave ‎ 00:25:56 Dr. Rasmussen describes how the job stress severely affected her health, causing panic attacks manifesting as chest pain and dangerously high blood pressure (190/110 with a heart rate of 197). One night after seeing the clinic and call schedule, she couldn't calm down despite trying mindfulness techniques. Her husband witnessed this and declared, "We are done here." Additional factors influencing her decision included the death of a mentor and her mother's illness. Dr. Rasmussen realized that despite her efforts, the team at Seattle Children's was unwilling to accommodate her career needs, which she viewed as a "breach of contract" - not from the institution but from the team that should invest in its members. Family Considerations in Career Decisions ‎ 00:28:55 Dr. Rasmussen discusses the challenge of considering another move so soon after relocating her family during the pandemic. She worried about uprooting her children who had just established connections in Seattle. A turning point came when her oldest child told her, "Mom, I think it's time for you to worry about yourself. I'm going to be okay." For her job interviews, she took the unusual step of requesting that both potential employers bring her entire family for second visits, not just her spouse. She received advice that "how happy do you think your family can be if mom is not happy?" and realized that many children move multiple times during childhood without negative consequences. She also learned that her oldest child had been bullied at their previous school, reinforcing that staying in Virginia might not have been better for her family. Finding the Right Partner and Environment ‎ 00:47:08 Dr. Rasmussen describes how she connected with her new boss by cold-calling him about a position at his former institution and inquiring if he needed a partner in his new program. Their initial conversation revealed shared vision and energy for building a program. Unlike her experience in Seattle, her new boss explicitly stated, "You tell me what you need out of a case, and that's what will happen," emphasizing team function over hierarchy. She contrasts this with her previous experience, noting the difference between a hierarchical environment and one with a shared vision. When she experienced a serious complication in her first liver transplant at the new institution, her partner provided support without judgment, wouldn't let her isolate herself, and eventually told her "it's time to stop" ruminating, while acknowledging that such complications happen to everyone. Growth and Support in the New Position ‎ 00:54:01 Dr. Rasmussen shares how her new environment supports her growth through challenging cases. During her first on-call experience, she consulted on a 1.6-kilogram baby with duodenal atresia. Though initially planning an open procedure, she researched laparoscopic approaches and found evidence supporting minimally invasive surgery for this condition. When she proposed this to her boss, he gave no pushback and even came to observe the successful procedure. Three months later, when she hesitated about performing a laparoscopic cholecystectomy on an eight-week-old baby, her boss reminded her, "Three months ago, you did a lap duodenal atresia repair on a 1.6 kilo baby - get over it," encouraging her to trust her abilities. Dr. Rasmussen appreciates how her partner recognizes when her tendency to overthink is a strength (when writing policies or justifications) and when it's holding her back. Reflections on Career Transitions and Lessons Learned ‎ 01:00:00 Dr. Rasmussen and Dr. Vertries reflect on the lessons learned through this career journey. Dr. Rasmussen acknowledges how she overcame limiting beliefs such as "I can't move because it will hurt my family" and "I can't have an ideal partner." Dr. Vertries notes that Dr. Rasmussen has experienced a "hero's journey" and that her lessons will have an "exponential effect on other people." Dr. Rasmussen expresses gratitude for the opportunity to reflect on how far she's come in a relatively short time, demonstrating that "you can make some pretty life-altering things in a short period of time with a little bit of help." Action Items Dr. Vertries mentioned reaching out to her at bosssurgery.com for help with toxic job situations. ‎ 00:00:35 Dr. Rasmussen suggested asking detailed questions about job expectations and case allocation when interviewing for new positions. ‎ 00:13:54 Dr. Rasmussen recommended bringing family members on second job interviews when considering relocation. ‎ 00:29:58 Dr. Rasmussen advised seeking coaching before leaving a job to process the situation properly. ‎ 00:42:17 Dr. Rasmussen suggested researching evidence-based approaches to surgical techniques when considering new procedures. ‎ 00:55:57

When someone is thought to have a brain tumor procedures to make the diagnosis may be risky or invasive, so a new test developed by Chetan Bettegowda, director of the department of neurosurgery at Johns Hopkins and colleagues is a … Can assessments of brain cancers be done with cerebrospinal fluid? Elizabeth Tracey reports Read More »

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test's developers.  … Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports Read More »

Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this … Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports Read More »

In this episode, we sit down with Dr. Joel Sunshine, Assistant Professor and Program Director of the Johns Hopkins Dermatology Residency. Dr. Sunshine is a board-certified dermatologist and dermatopathologist whose work spans clinical care, education, and translational research.He shares his journey into dermatology, what residents can expect from the Hopkins program, and his advice for medical students exploring the field. Tune in to hear how curiosity, mentorship, and innovation shape the residency experience at Johns Hopkins. We hope you enjoy!Learn More about Johns Hopkins Dermatology:Instagram: @hopkinsdermresidencyWebsite: Johns Hopkins Dermatology Residency---DIGA Instagram: @⁠derminterest⁠---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠---Music: "District Four" Kevin MacLeod (⁠⁠⁠⁠⁠⁠⁠⁠incompetech.com⁠⁠⁠⁠⁠⁠⁠⁠) Licensed under Creative Commons:By Attribution 4.0 License:⁠⁠⁠⁠⁠⁠⁠⁠ http://creativecommons.org/licenses/by/4.0/

RFK Jr.'s autism claims aren't about helping anyone—they're about deciding who gets to exist in America.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are distressed by the continuing government shutdown, first locally acquired chikungunya virus infection, President Trump's suggestion for removing aluminum from vaccines, H5N1 isolation from backyard birds and turkey farms, and the suggestion of establishing an alternative to the CDC's MMWR and asymptomatic measles infections before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the quarantining in the US due to measles, access to anti-influenza antiviral, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, if colchicine is effective for long COVID, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode New York health officials confirm state's first locally acquired case of chikungunya virus (AP News) Trump Rattles Vaccine Experts Over Aluminum (NY Times) Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood (Annals of Internal Medicine) Three large turkey farms in Minnesota hit with H5N1 avian flu (CIDRAP) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Jeffrey Lee McLean (California.No) California mpox cases raise concerns. But health officials say the risk remains low (AP News) ‘Alternative' to CDC's Flagship Journal in the Works (MEDPAGE TODAY) Measles without rash during acute febrile illness surveillance in Tanzania, 2023-2024 (CID) Frustration grows amid measles outbreak quarantines across several states (NBC News) More Than 100 Cases of Measles Reported in Utah and Arizona (NY Times) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine recommendations from NYP (jpg) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) Roche to sell flu pill for $50 to cash-paying US patients (Reuters) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults (CID) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Effectiveness of Colchicine for the Treatment of Long COVID(JAMA Internal Medicine) Reaching out to US house representative Letters read on TWiV 1264 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Dr. John Gartner joins the Beast's Joanna Coles to assess the unraveling of Donald Trump's mind. The clinical psychologist and former Johns Hopkins professor, who warned early about Trump's “malignant narcissism,” now says the president shows clear signs of cognitive decline, comparing his confusion and grandiosity to dictators in their final stages. Coles presses Gartner on whether Trump's dementia makes him more dangerous or simply more delusional, and what that means for the remainder of Trump's second term and beyond. Is America being led by a man losing touch with reality, or is Trump still cunning enough to conceal his growing symptoms? Hosted on Acast. See acast.com/privacy for more information.

Comincia oggi un Consiglio europeo dedicato soprattutto alle crisi internazionali, Ucraina in primis.Nonostante le divisioni nell'Ue i leader di Regno Unito, Italia, Germania, Francia, Polonia, Finlandia, Norvegia, Danimarca, Spagna e Svezia in una dichiarazione congiunta hanno confermato «il sostegno alla posizione del presidente Trump secondo cui i combattimenti devono cessare immediatamente, e l'attuale linea di contatto diventare il punto di partenza del negoziato».Ne parliamo con Antonio Missiroli, consigliere scientifico dell'Ispi, docente alla Johns Hopkins di Bologna e Science Po di Parigi e Gastone Breccia, insegna Storia bizantina e Storia militare antica presso l'Università di Pavia.

Key PointsDeborah's symptoms began in 2013 with weakness in her legs and lower extremities, initially misdiagnosed by her family doctor who recommended exercise and weight loss for two years.A CAT scan revealed the AVM was located in the very pit of Deborah's spinal cord inside the cord itself, requiring immediate hospitalization due to risk of catastrophic paralysis.Deborah underwent her first eight and a half hour neurosurgery while positioned face-down with electrodes monitoring her body, but the surgeon was unable to remove all the problematic veins.Following the incomplete first surgery, Deborah was told she would need additional operations and that her condition would worsen without further intervention.After four years of deterioration, Deborah underwent a second eight-hour operation at Johns Hopkins where surgeons successfully removed the remaining vein.Prescription medications including opioids, tramadol, oxycodone, gabapentin, and baclofen provided minimal pain relief while causing significant side effects and dependency.Megan Hall, working in film in Los Angeles, began researching cannabis health benefits as an alternative to help her mother avoid opioid dependency and early death.Al Marenton of My Fit Life offered to help Deborah after meeting Megan at a cannabis event in 2016, creating a CBD-dominant RSO with no THC to avoid medical benefit complications.Initial CBD usage was inconsistent due to Deborah's concerns about saving the product, until Megan and Al established a regular dosing regimen.Deborah successfully discontinued tramadol while continuing CBD treatment, experiencing complete elimination of her thoracic back pain and improved mobility including riding a three-wheel bike.Medical professionals initially discouraged CBD use due to insurance and testing concerns, but Deborah's pain management doctor recently expressed approval of her CBD-only pain management approach.Deborah now lives independently using only CBD for pain management, drives, and uses a walker for mobility assistance while remaining completely free of opioid medications. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee begin a two-part forensic review of the 2011 death of Ellen Greenberg, a young woman found with more than twenty stab wounds in her Philadelphia apartment. Despite the severity and location of her injuries, Ellen’s death was ruled a suicide not once but twice. In part one, Dr. Priya walks listeners through the science of sharp-force injuries, defines key forensic terminology, and explains why certain wound patterns, especially those to the back of the head and neck, raise significant questions about how this case was ever closed. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl McCollum and Dr. Priya introduce the Ellen Greenberg case and outline the official findings (2:00) Dr. Priya defines sharp-force injuries and explains the difference between stab and cutting wounds (6:45) Identifying single-edged versus double-edged blades and how wound shape reveals the type of weapon (8:00) Understanding defensive wounds and what their presence means (10:30) The classification of cause and manner of death and why Ellen Greenberg’s case remains controversial (13:45) How and why medical examiners revisit cases when new information or legal action arises (16:30) Reviewing Ellen’s autopsy and toxicology results (18:45) Why stab wounds to the back of the head and neck are nearly impossible to self-inflict and what that reveals about this case About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Solar and wind power are outpacing coal for the first time globally. However, the US faces challenges in meeting clean energy goals due to material shortages, a lack of skilled workers, and political roadblocks. Sign up now for Uptime Tech News, our weekly email update on all things wind technology. This episode is sponsored by Weather Guard Lightning Tech. Learn more about Weather Guard's StrikeTape Wind Turbine LPS retrofit. Follow the show on Facebook, YouTube, Twitter, Linkedin and visit Weather Guard on the web. And subscribe to Rosemary Barnes' YouTube channel here. Have a question we can answer on the show? Email us! Something remarkable happened this year. For the first time in history, renewable energy generated more power than coal worldwide. Solar grew thirty-one percent in just six months. Wind and solar together outpaced electricity demand. China built more clean energy in half a year than the rest of the world combined. India's renewable growth beat demand. Their fossil fuel use dropped. Why? Simple economics. Wind and solar are now the cheapest sources of electricity. But here in America, we have a problem. Johns Hopkins researchers just discovered we'll fall thirty-four percent short of our clean energy goals by twenty fifty. Not because renewables cost too much. Because we don't have the materials to build them. Nickel. Silicon. Rare earth elements with names like neodymium and dysprosium. China controls ninety percent of the processing. And last week, they announced export controls. Meanwhile, in Britain... They're creating four hundred thousand clean energy jobs by twenty thirty. Plumbers. Electricians. Welders. Building wind farms. Installing solar panels. Running smart grids. Energy Secretary Ed Miliband put it simply: "Where are the good jobs of the future going to come from? This is the answer." The Sizewell C nuclear plant alone needs ten thousand workers. But here's the rub - they need to triple their welders, double their plumbers. The workers don't exist yet. Down in North Carolina... Duke Energy just announced a new plan. They're delaying wind projects. Extending coal plants. Not because coal is cheaper - it isn't. But because artificial intelligence and data centers are driving electricity demand eight times faster than expected. Glen Snider from Duke says they need reliability while demand surges. The irony? Duke's moving away from the cheapest new sources of power - wind and solar - just when they need the most electricity. They're choosing to extend expensive coal plants that cost more to run. Australia sees opportunity... Treasurer Jim Chalmers is in New York meeting with Blackstone and Wall Street. Australia has lithium, manganese, rare earths. They claim they can deliver the world's lowest-cost renewable electricity by twenty fifty. "Australia has exactly what the world needs, when the world needs it," Chalmers says. Think about this... The technology works. Solar and wind are cheaper than coal. Batteries can store the power. Countries using these technologies are seeing their energy costs drop. But America faces three bottlenecks: First, we don't control the materials. Second, we don't have the skilled workers. Third, states like North Carolina are choosing reliability over cost savings. President Trump calls renewables "a joke." But JP Morgan says something different. They say America will have to use renewable energy whether we like it or not. Nuclear takes too long to build. Fossil fuels cost too much. The numbers tell the story... Britain: Four hundred thousand new jobs. America: Seven hundred thirty gigawatts short of materials. North Carolina: Eight times the demand growth. Global renewables: Cheaper than coal for the first time. We're watching the free market work. The cheapest energy is winning worldwide. Except in places where politics and supply chains get in the way.

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. … When you have screening colonoscopy should you worry about the endoscopist's skills? Elizabeth Tracey reports Read More »

If you've been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to … Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports Read More »

People who've had colorectal cancer and who have a mutation known as  PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson:  There were … What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports Read More »

If you've ever been part of the cystic fibrosis community, you've probably heard of the sweat chloride test, maybe you've even had one yourself. But what does that test really measure, and why does it still matter in the age of CF modulators?Laura talks with Dr. Patrick Sosnay, Vice President and Head of CF Development at Vertex Pharmaceuticals. Before joining Vertex, Dr. Sosnay was a clinician and researcher at Johns Hopkins, where he helped define the genetic criteria for diagnosing CF and co-founded the influential CFTR2 database.Dr. Sosnay brings his expertise, and a gift for explaining complex science.  He unpacks the real story behind sweat chloride testing. Together, we explore:* What the sweat test actually measures — and how it connects to the CFTR protein.* Why sweat chloride is still vital long after diagnosis.* How researchers use it to track CF progression and measure treatment success.* What all this means for people living with CF and their families today.This episode redefines the sweat chloride test as more than just a diagnostic number, it's a powerful marker of health, innovation, and hope for the future.Listen now and gain a fresh perspective on one of the most familiar, yet evolving  parts of cystic fibrosis care.(Vertex is a sponsor of this podcast. The Bonnell Foundation remains committed to transparent, balanced conversations that serve the CF community first.)Additionaly we explore:What the sweat test measures and how it's tied to the CFTR protein (cystic fibrosis transmembrane conductance regulator).Why sweat chloride remains important well beyond diagnosis.How researchers use it to understand CF progression and evaluate new treatments.What this means for families and patients living with CF every day.This episode shares the reframing of the sweat chloride test, not as a simple number, but as a meaningful marker of health, research, and hope for the future. Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are dismayed by the government shutdown, the firings at the CDC including EIS agents, H5N1 isolation from backyard birds and its stability in raw milk and cheese, before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the quarantining of college students in the US due to measles, Japan's declaration of a national influenza outbreak, effectiveness of the influenza and COVID vaccines, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, results from PLATCOV studies- still no antiviral activity attributed to ivermectin, where to go for answers to your long COVID questions, long COVID in pediatrics, patient reported outcomes from the STOP-PASC clinical trial, contacting your federal government representative to stop the assault on science and biomedical research and the listener reminder that measles vaccine in those with interferonopathy may result in severe adverse affects. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Trump Administration Lays Off Dozens of C.D.C. Officials (NY Times) CDC walks back hundreds of firings as US shutdown persists (Yahoo News/ Reuters) CDC battered by government shutdown firings, while some are rescinded (STAT 10) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Flurry of H5N1 activity noted in commercial poultry, wild birds(CIDRAP) H5N1 influenza virus stability and transmission risk in raw milk and cheese(Nature Medicine) Hundreds of U.S. students quarantined amid measles outbreaks (NBC News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Japan sees early flu activity, with school closures(CIDRAP) Japan Declares Nationwide Flu Outbreak Following Early Surge in Cases (insightscare) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Effectiveness of influenza vaccination to prevent severe disease (CMI: Clinical Microbiology and Infection) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents (The Pediatric Infectious Disease Journal) Trump gets Covid vaccine and flu shot during second checkup of the year (NBC News) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)(eLife) Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV) (LANCET: Infectious Diseases) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection (JAMA Internal Medicine) Longitudinal patient-reported outcome trajectories in Long COVID: Findings from the STOP-PASC Clinical Trial (OFID) Reaching out to US house representative Severe Adverse Reaction to Measles Vaccine Due to Homozygous Mutation in the IFNAR2 Gene: A Case Report and Literature Review (Journal of Clinical Immunology) Letters read on TWiV 1262 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode, Dr. T.Y. Alvin Liu, Inaugural Director of the AI Innovation Center at Johns Hopkins Medicine, shares how one of the nation's top academic health systems is pioneering AI implementation, governance, and the future of oculomics. He unpacks the challenges of real-world deployment and why collaboration and rapid iteration are key to success.

In this powerful episode, I was joined by the incredible Dr. George Grant, founder of the Academy of Wellness.

In this episode, we sit down with Charlie Pearson, senior offensive tackle at Johns Hopkins University and member of the Allstate AFCA Good Works Team. Charlie helped lead the Blue Jays to a 12-2 record, a Centennial Conference Championship, and a historic trip to the 2024 NCAA Division III Semifinals — all while maintaining a 3.87 GPA as a Public Health major. Recognized as the Centennial Conference Football Scholar-Athlete of the Year, he's the definition of excellence on and off the field. Off the gridiron, Charlie serves as a certified EMT responding to 911 calls in Baltimore, mentors youth through Blue Jays for Baltimore, supports returning citizens through Turnaround Tuesday, and leads fundraising efforts for children's health with HopThon. Join us as we explore how Charlie balances football, academics, and community service — and what it means to be a student-athlete making an impact beyond the game. Follow @hopkinsfootball on social media for more.

Do you live in a way that maximizes your well-being? Chances are, the answer to that question is no. Our modern way of living, some suggest, is incompatible with a thriving lifestyle. While the notion that many factors impact our overall health and wellness is not necessarily far-fetched, you may be surprised by the argument that some of the strongest factors are relational — both with one another and with the earth. Family Physician and public health professor Dr. Wendy Johnson explores this concept in her newest book, Kinship Medicine: Cultivating Interdependence to Heal the Earth and Ourselves. Johnson asserts that the solution to many of the causal factors of poor health — loneliness, industrial diets, systemic inequality, profit-based healthcare — are about humanity's interconnectedness to people and planet. Examples in Kinship Medicine include information on how trauma can be passed down for generation and how eliminating one organism in an ecosystem can affect all others. Her work also posits that our relationship to non-human life is essential to our well-being, and community action is stronger than individual efforts. With examples from public health, sociology, anthropology, human ecology, and her experience as a doctor, Dr. Johnson advocates for a shift in society that could lead to a healthier future. Wendy Johnson is a family physician, public health professor, activist and writer who has spent her life advocating for a world where everyone can live long lives in equitable communities. Her career includes stints scaling up HIV treatment in Mozambique, overseeing an urban health department, and most recently, directing a community clinic in Santa Fe. She has a Master of Public Health from Johns Hopkins and holds faculty appointments at the University of Washington and the University of New Mexico. She currently practices family and addiction medicine in rural Northern New Mexico with El Centro Family Health. Dr. Johnson has been a vocal activist on many progressive issues locally and globally and is a two-time TEDx speaker. Tessa Hulls is an artist, writer, and adventurer who is equally likely to disappear into the backcountry or a research library. Her debut graphic memoir, Feeding Ghosts, received the National Book Critics Circle John Leonard Prize, the Libby Book Award, and the Anisfield-Wolf Award, and was a finalist for the Kirkus Prize and the Pacific Northwest Book Award, and nominated for the Carnegie Medal for Excellence in Nonfiction. She's pivoting her career to fuse her two great loves of creativity and the wilderness by becoming a comics journalist working with field scientists studying ecological resilience and climate change in remote environments, and she would love to hear from you if you want to partner with her on this endeavor. Buy the Book Kinship Medicine: Cultivating Interdependence to Heal the Earth and Ourselves Third Place Books

Join Lynn Hoffman for this new episode of Music Saved Me with Doctor Tasha Golden. From touring musician to Johns Hopkins scientist - Dr. Tasha Golden’s journey through creative burnout led her to pioneer “arts on prescription” research. She shares how music both broke and remade her, and what science reveals about creativity’s power to heal. A raw, hopeful conversation about transformation, resilience, and why your doctor might soon prescribe you a concert. Support the show: https://takinawalk.com/See omnystudio.com/listener for privacy information.

Join Lynn Hoffman for this new episode of Music Saved Me with Doctor Tasha Golden. From touring musician to Johns Hopkins scientist - Dr. Tasha Golden’s journey through creative burnout led her to pioneer “arts on prescription” research. She shares how music both broke and remade her, and what science reveals about creativity’s power to heal. A raw, hopeful conversation about transformation, resilience, and why your doctor might soon prescribe you a concert. Support the show: https://musicsavedme.net/See omnystudio.com/listener for privacy information.

Reinvention often begins with a single moment that changes how we see our lives and the impact we want to make. Michelle Bockman, CEO of KeraLink International, shares her story and it reminds us what can happen when vision and purpose align.Michelle's story is one of true reinvention. After building a remarkable corporate career across Fortune 100 companies and Silicon Valley startups, she found herself at a crossroads. Around that same time, life threw her an unexpected curveball, she lost the central vision in her right eye due to a rare condition. During her treatment, doctors also discovered cancer in her other eye.What happened next changed everything. While Michelle regained her full 20/20 vision after treatment at Johns Hopkins, the experience opened her eyes (literally and figuratively) to a new calling, leading KeraLink International, a nonprofit focused on ending preventable blindness around the world.Michelle has completely reimagined what a modern nonprofit can be. She's built an ecosystem that includes:Community Programs that bring eye screenings and care to underserved areas.KeraX Venture Studio, developing affordable eye-care technologies that can be used anywhere in the world.KeraLink.com, an eyewear brand where 100% of the profits go right back into funding care.One of my favorite parts of our conversation was hearing how they're training women health workers in India who go door-to-door to help families get care. These women are finding new confidence, independence, and purpose creating ripple effects that go far beyond vision care.“When vision meets purpose, everything becomes clear.” — Michelle BockmanMichelle's story is a powerful reminder that reinvention is about embracing unexpected opportunities and being open to possibilities.Action Step: Take a quiet moment this week to ask yourself: What part of my story is ready to be seen in a new light? Sometimes clarity begins when we give ourselves permission to look again.About Michelle Bockman:Michelle Bockman is President & CEO of KeraLink International, a nonprofit focused on reducing corneal blindness globally by expanding eye care accessibility. With 25+ years of leadership at Fortune 100s and Silicon Valley startups, she brings strategic vision and a passion for innovation to her mission-driven role.Find out more:https://www.linkedin.com/in/michellebockman/https://keralink.orgLinkedIn: https://www.linkedin.com/company/keralink-international/YouTube: @KeraLinkInternationalInstagram: @keralink_internationalFacebook: https://www.facebook.com/KeraLinkIntlKeep shining your light bright. The world needs you.Connect with Natalie BenamouNatalie Benamou is Founder of HerCsuite®, the first professional women's network infusing AI into courses, masterminds for women leaders, board directors and entrepreneurs. She also serves as President and CEO of HER HEALTHX, a nonprofit bridging the care communication gap and improving health outcomes for women.

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” with discussions about evolution and intelligent design. Dr. Casey Luskin joined us to discuss his faith story and his experience as a scientist who advocates for intelligent design. Dr. Luskin is a scientist and an attorney with graduate degrees in science and law. He has been a California-licensed attorney since 2005, practicing in the area of evolution-education in public schools and defending academic freedom for scientists who face discrimination because they support intelligent design. He also co-founded the Intelligent Design and Evolution Awareness (IDEA) Center, a nonprofit organization that helps students on college and high school campuses. Then we had Dr. William West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” Then we had Dr. Fazale Rana, also known as “Dr. Fuz,” join us to share his story and discuss some advancements in biotechnology and their impact on transhumanism. Dr. Fuz is the President, CEO, and Senior Scholar at Reasons to Believe. He also holds a PhD in chemistry with a focus on biochemistry from the University of Ohio. He also wrote the book, “The Cell’s Design (Reasons to Believe): How Chemistry Reveals the Creator’s Artistry.” You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Dr. Casey Luskin Interview [03:37 ] Dr. Fazale Rana “Dr. Fuz” Interview [37:39 ] Dr. William West Interview [58:53 ] Caller Response (You were a Skeptic of Science and Now You're a Believer) [01:08:38 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Host Jason Blitman talks with Megha Majumdar about her acclaimed second novel, A Guardian and a Thief—recently nominated for the Kirkus Prize and shortlisted for the National Book Award.Conversation highlights include:

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

Before a body is ever opened, a medical examiner must consider what dangers might be waiting inside: fentanyl, tuberculosis or even a hidden needle. This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee share stories from their recent visit to Lake Tobias Wildlife Park. There, they took part in Wildlife CSI training, a hands-on blend of forensic education and animal encounters, including time with Chester, a baby kangaroo who quickly won everyone over. From there, the conversation shifts to the serious risks medical examiners face every day. From bloodborne pathogens and drug exposure to unstable death scenes and unpredictable infections, Dr. Priya offers a closer look at the hidden hazards behind every autopsy. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl and Dr. Priya open the episode with highlights from the Wildlife CSI training at Lake Tobias Wildlife Park (3:15) Embracing lifelong learning, from seasoned investigators to students in the field (4:45 Honoring Dr. Jane Goodall and recognizing how wildlife crime intersects with forensic science (6:30) The hidden dangers of autopsy work: COVID, drug exposure, and unknown infections (8:30) Safety in the morgue: scalpel slips, needle sticks, and the rise of pandemic-era protocols (12:30) Fentanyl, MRSA, TB, and the health risks involved in cases with limited medical histories or unidentified individuals (17:00) Environmental hazards at the death scene, from fire damage and rough terrain to unpredictable animals (22:15) Morgue myths, pet protection, and why even the smallest details can carry big dangers About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

These are the things that make up Division III football this time of year. W's and L's as in wins and losses, X's and O's as in how plays and schemes are drawn up on paper, and 0's and 1's as in the data that is used to determine who will make the playoffs and how they'll be seeded, in the NCAA Power Index. We got the first look at the NCAA's version of the data in the NPI this week, and no surprise to anyone here that the data fully passed inspection and is exactly the same as what we've seen on D3datacast -- that's the link on our home page menu, for your reference. Of course, there were some great games to run down this week, such as how the folks at Johns Hopkins put together a third- and fourth-quarter rally to get past Carnegie Mellon. We talk about how the game turned, what can be learned, how the teams can grow from here. Hardin-Simmons/Mary Hardin-Baylor and Berry-Trinity (Texas) were big games that ended up not being close. What's up with UMHB? And we also chat with Tony Kunczewski, the head coach at Berry, about his team's big day and their win in our Fast 5 segment. And yes, there were upsets in the WIAC. Or were there? What really constitutes an upset in WIAC games these days? Co-hosts Patrick Coleman and Greg Thomas talk it through.  Patrick and Greg hand out game balls, spotlight the unusual stats of the week, Logan Hansen talks about which teams have the best chance of getting a top-eight seed and protected home field in the playoffs, we go around each region for even more stories and much more in this edition of the D3football.com Around the Nation podcast.

Imagine an engineer who's gone from writing code to building a venture-backed startup—now creating AI-powered tools tailored for fashion brands in New York. That's Harish Chandramowli, Co-Founder of Flaire. His journey is a compelling example of the kind of leadership, innovation, and resilience we highlight on the Breakfast Leadership Show. With a twelve-year engineering career at organizations like MongoDB, Bloomberg, and Johns Hopkins, Harish made the leap into entrepreneurship by co-founding Flaire—an ERP platform that fuses artificial intelligence with user-centered design for retail. What makes Harish's story stand out is his ability to blend deep technical expertise with the gritty, hands-on realities of scaling a business. Whether he's designing smarter code-review workflows (like Greptile, which dramatically reduces dev feedback cycles) or jumping into client sales conversations, Harish brings a unique perspective. He's learned firsthand how to build high-performing remote teams rooted in trust, and how small, strategic process bets can drive sustainable growth. LinkedIn: https://www.linkedin.com/in/scharish/ Website: https://Flairesoftware.com This episode's partner is MRPeasy.  Link to sign up:  https://try.mrpeasy.com/rzhgcr9jcov5   The AI-powered MRP software for small manufacturers Ideal for companies with 10 - 200 employees MRPeasy is a seriously powerful yet easy-to-use manufacturing software. It gives you everything you need to manage your manufacturing and distribution.  

According to a 2024 World Health Organization study, over the last 50 years vaccines have saved over 154 million lives worldwide from over 20 life threatening diseases. As vaccines are facing skepticism, we are here to cut through the noise and lay out the facts as to why staying up-to-date on vaccinations is especially important for kidney patients. This episode is supported by Moderna.  In today's episode we heard from:  Mary Baliker has been a dedicated healthcare advocate for the past 40 years, and is involved in several kidney initiatives regionally, nationally and globally. Mary was diagnosed with a rare kidney disease at the age of nine and since then has undergone hemodialysis and received four kidney transplants. As a result of this life-long journey, Mary cherishes her life and possesses a strong desire to help improve the healthcare experience, health outcomes and quality of life for patients with kidney disease. In addition to publishing multiple peer reviewed articles related to the kidney patient experience, Mary is the author of Maria Never Gives Up, a story written to help children and families facing chronic illnesses. Her book is distributed across transplant and dialysis centers nationwide and is available for purchase online William Werbel, MD, PhD is a transplant infectious diseases physician and scientist at Johns Hopkins focused on optimizing protection against infections in immunocompromised persons. He completed clinical and research fellowship in infectious diseases at Johns Hopkins following MD training at the University of Michigan and internal medicine residency and chief residency at the Northwestern Feinberg School of Medicine. He is the current Associate Director for Epidemiology and Quantitative Sciences in the Johns Hopkins Transplant Research Center and principal investigator of the national Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) cohort study. He receives NIH funding to study the landscape of infections in transplant recipients and evaluate the real-world impact of vaccination using a combination of epidemiological and laboratory approaches. Additional Resources: Vaccines for CKD Patients Vaccine Integrity Project IDSA Immunization Resources Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) Study   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about Jane Goodall's death and the Nobel prize in Physiology/Medicine for understanding immune system control before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, if 2 doses of the influenza vaccine are better for protection of first season children, if COVID-19 negatively impacts pregnancy and the unborn child, efficacy of long-acting monoclonal antibody against symptomatic COVID-19, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, long COVID in pediatrics, association of COVID-19 with new-onset vascular dementia and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Jane Goodall's legacy: three ways she changed science (Nature) They understood how the immune system is kept in check (The Nobel Prize) Daniel Griffin: The Nobel Prize for Understanding Autoimmune Disease (WNYC: New York Public Radio) Kennedy's Ties to Ally Leading Vaccine Lawsuits Raise Ethical Concerns (NY Times) Ebola outbreak in southern Congo shows signs of containment with no new cases, WHO reports (AP News) Ebola Disease (WHO: African Region) Premature baby dies from measles in Alberta as cases throughout province near 2,000(Global News) DOH Issues Advisory After Measles Detection in City of Oswego Wastewater (Finger lakes dailynew.com) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season (CDC: MMWR) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza (JAMA: Open Network) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines(Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Neonatal outcomes among pregnant women with COVID-19 (BMC Pregnancy and Childbirth) Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19 (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity (CID) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR) (LANCET: Infectious Diseases) Prevalence and duration of clinical symptoms of pediatric long COVID (Frontiers in Pediatrics) COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years(NPJ| dementia) Reaching out to US house representative Letters read on TWiV 1260 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

On the heels of being honored at Bronx Lacrosse's annual fundraiser, Chair of the USA Lacrosse Foundation Board and Johns Hopkins alum joins IL's Terry Foy to discuss the many different aspects of the sport that he touches, from Team USA's Olympic aspiration to grassroots development, from being the dad of a '27 who just committed to North Carolina to being a PLL investor and NLL team owner. Check out the wide-ranging conversation with one of lacrosse's most interesting and influential voices.

What if the autistic children of today are showing us the next stage of human consciousness, where telepathy, intuition, and deep connection are completely natural?In today's episode, Ashley sits down with Dr. Diane Hennacy Powell, MD, an internationally recognized expert on autism, savant syndrome, and consciousness. Her groundbreaking research has been featured in The Telepathy Tapes, where she explores extraordinary communication abilities among autistic children. A neuroscientist trained at Ohio State and Johns Hopkins, Dr. Powell has devoted her career to understanding the mind's hidden capacities and the bridge between science and spirituality. Together, Ashley and Diane explore how telepathy is not just a phenomenon of gifted savants, but a glimpse into humanity's evolving consciousness.Tune in to Episode 286 of Uncover Your Magic to rediscover your own intuitive potential and see the world through a new lens. You'll hear about the scientific roots of telepathy, how autistic children are teaching us about oneness, and the future of education and consciousness. Plus, Diane shares the fascinating story of her research in India, her encounters with “blue light beings,” and her mission to reunite science with spirit.When we remember that we are all connected beyond words, we unlock a level of communication that transcends time and space — and reconnect with the magic that's always been within us.Episode Takeaways (timestamps)00:04:00 – Diane's early scientific training and first experiences with telepathy00:19:00 – How her medical career led to a psychic encounter that changed everything00:37:00 – The autistic savants who communicate telepathically and what they teach us about consciousness00:53:00 – The mystery of the “blue light beings” and the shift in planetary awareness01:07:00 – The future of education, intuition, and why humanity is ready for a new paradigmResources & LinksConnect with Dr. Diane Hennacy Powell: Website • Twitter/XRecommended Resource: The ESP Enigma – Signed copies available through her websiteLet's Connect!Connect with Ashley: Website • Instagram • FacebookYour Next Move: Subscribe to Uncover Your Magic PodcastShare with a Friend: Simply forward this email, it's that easy or tag them on socialFree Gift: Download your Easy Magical Morning Routine for Busy People Hosted on Acast. See acast.com/privacy for more information.